Improving the anti-keloid outcomes through liposomes loading paclitaxel–cholesterol complexes

BACKGROUND: Keloids represent benign fibroproliferative tumors which result from elevated expression of inflammation. Paclitaxel (PTX) was an effective chemotherapeutic agent and has been reported to have anti-fibrotic effects, but the strong hydrophobicity brings a challenge for its clinical applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengjiao, Chen, Liqing, Huang, Wei, Jin, Mingji, Wang, Qiming, Gao, Zhonggao, Jin, Zhehu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390862/
https://www.ncbi.nlm.nih.gov/pubmed/30863067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390862/
https://www.ncbi.nlm.nih.gov/pubmed/30863067

Ejemplares similares